Suppr超能文献

早期Masaoka分期及完整切除对胸腺癌预后很重要:单机构20年经验

Early Masaoka stage and complete resection is important for prognosis of thymic carcinoma: a 20-year experience at a single institution.

作者信息

Lee Chang Young, Bae Mi Kyung, Park In Kyu, Kim Dae Joon, Lee Jin Gu, Chung Kyung Young

机构信息

Department of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine, Seoul, Republic of Korea.

出版信息

Eur J Cardiothorac Surg. 2009 Jul;36(1):159-62; discussion 163. doi: 10.1016/j.ejcts.2009.02.019. Epub 2009 Mar 25.

Abstract

OBJECTIVE

Prognosis of primary thymic carcinomas is poor due to advanced stage progression at diagnosis and highly malignant behavior. We retrospectively evaluated patients with thymic carcinoma to determine the prognostic factors.

METHODS

Sixty patients diagnosed and treated for thymic carcinoma from 1986 to 2005 were reviewed retrospectively. Influences of demographic characteristics, Masaoka stage, histologic grade, completeness of resection and adjuvant treatment on survival were evaluated. We defined complete resection as macroscopically and microscopically total resection of a tumor (R0 resection) and incomplete resection was subdivided into microscopic incomplete resection (R1 resection) or macroscopically incomplete resection (R2 resection).

RESULTS

There were 42 male and 18 female patients and mean age was 53.9 (+/-14.4) years old. The 5-year overall survival rate was 38.8% and median survival time was 35.6 months. The most common histologic type was squamous cell carcinoma (n=29). In our study, 5 patients (8.3%) were in Masaoka stage I, 5 (8.3%) were in stage II, 19 (31.7%) were in stage III, 15 (25.0%) were stage in IVa, and 16 (26.7%) were in stage IVb. Among 40 patients who underwent surgical resection, complete resection was achieved in 14 patients. The 5-year survival rate after complete resection was 85.1% and was considered significantly better than those after incomplete resection (29.0%, p=0.001) and non-surgical treatment (16.7%, p<0.001). But, no survival difference could be found between the incomplete resection group and non-surgical treatment group (p=0.15). The 5-year survival rates of early Masaoka stage patients were significantly higher than advanced Masaoka stage (90.0% vs 28.3%, p=0.001). The recurrence rates within 3 years after R1 resection (75.0%) were significantly higher than that after R0 resection (14.9%, p=0.008).

CONCLUSIONS

In thymic carcinoma, complete resection of early Masaoka stage lesions is the most important factor for disease control and long-term survival of patients.

摘要

目的

原发性胸腺癌的预后较差,因为在诊断时疾病已处于晚期进展阶段且具有高度恶性行为。我们对胸腺癌患者进行了回顾性评估,以确定预后因素。

方法

回顾性分析了1986年至2005年期间诊断并接受治疗的60例胸腺癌患者。评估了人口统计学特征、Masaoka分期、组织学分级、切除完整性及辅助治疗对生存的影响。我们将完整切除定义为肿瘤在宏观和微观层面均完全切除(R0切除),不完全切除细分为微观不完全切除(R1切除)或宏观不完全切除(R2切除)。

结果

患者中男性42例,女性18例,平均年龄53.9(±14.4)岁。5年总生存率为38.8%,中位生存时间为35.6个月。最常见的组织学类型为鳞状细胞癌(n = 29)。在我们的研究中,5例(8.3%)处于Masaoka I期,5例(8.3%)处于II期,19例(31.7%)处于III期,15例(25.0%)处于IVa期,16例(26.7%)处于IVb期。在40例行手术切除的患者中,14例实现了完整切除。完整切除后的5年生存率为85.1%,被认为显著优于不完全切除后(29.0%,p = 0.001)及非手术治疗后(16.7%,p < 0.001)的生存率。但是,不完全切除组与非手术治疗组之间未发现生存差异(p = 0.15)。Masaoka早期患者的5年生存率显著高于晚期患者(90.0%对28.3%,p = 0.001)。R1切除后3年内的复发率(75.0%)显著高于R0切除后(14.9%,p = 0.008)。

结论

在胸腺癌中,完整切除Masaoka早期病变是控制疾病及患者长期生存的最重要因素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验